Calliditas Therapeutics AB
CALT
Company Profile
Business description
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.
Contact
Kungsbron 1, D5
Stockholm SE-111 22
SWET: +46 84113005
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
219
Stocks News & Analysis
stocks
Going into earnings, Is Facebook parent Meta a buy, a sell, or fairly valued?
Watching ad demand, AI monetization, and platform usage.
stocks
2 ASX shares to avoid
An investor favourite is among the two shares trading at a significant premium to our fair value.
stocks
Is this ASX miner a bargain after shares plunge?
We think investors may have overreacted to recent news.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,205.50 | 3.10 | -0.04% |
| CAC 40 | 7,513.73 | 84.90 | -1.12% |
| DAX 40 | 18,387.46 | 170.24 | -0.92% |
| Dow JONES (US) | 39,853.87 | 504.22 | -1.25% |
| FTSE 100 | 8,153.69 | 13.68 | -0.17% |
| HKSE | 17,311.05 | 158.31 | -0.91% |
| NASDAQ | 17,342.41 | 654.94 | -3.64% |
| Nikkei 225 | 39,154.85 | 439.54 | -1.11% |
| NZX 50 Index | 12,419.85 | 111.14 | -0.89% |
| S&P 500 | 5,427.13 | 128.61 | -2.31% |
| S&P/ASX 200 | 7,963.70 | 7.40 | -0.09% |
| SSE Composite Index | 2,901.95 | 13.42 | -0.46% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Argosy Minerals Ltd AGY | 0.05 | 0.03 | -39.51% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
| Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -4.08% |
| South32 Ltd S32 | 2.96 | 0.02 | -0.67% |
| Zip Co Ltd ZIP | 1.83 | 0.03 | 1.39% |
| Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
| Worley Ltd WOR | 15.23 | 0.04 | 0.26% |
| Mesoblast Ltd MSB | 1.26 | 0.05 | -3.83% |
| Telstra Group Ltd TLS | 3.90 | 0.02 | 0.52% |